0.0637SEK-0.31%Mkt Cap: 25.15M SEKP/E: —Last update: 2026-05-13
SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical …
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B0.25
P/S38.76
EV/EBITDA-0.92
EV/Revenue21.26
EPS (TTM)-0.20
EPS (Forward)—
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF-24.03M SEK
CapEx (TTM)19.64M SEK
Net Debt/EBITDA0.72
Net Debt-10.74M SEK
Technical
SMA 500.0800 (-20.4%)
SMA 2000.1379 (-53.8%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)1.76M
Avg Vol (10d)1.52M
Technical Indicators
RSI (14)31.9
MACD-0.0052
MACD Signal-0.0052
MACD Hist.+0.0000
BB Upper0.0766 SEK
BB Middle0.0691 SEK
BB Lower0.0616 SEK
BB Width21.72%
ATR (14)0.0079 SEK
Vol Ratio (20d)0.90x
52W Range
0.05830% of range1.192
52W High1.192 SEK
52W Low0.0583 SEK
Profitability
Gross Margin618.85%
EBITDA Margin0.00%
Profit Margin0.00%
Oper. Margin-889.63%
ROE-59.95%
ROA-53.68%
Revenue Growth-43.30%
Earnings Growth—
Balance Sheet
Debt/Equity0.03
Current Ratio7.02
Quick Ratio6.91
Book Value/Sh0.2470 SEK
Cash/Share0.0340 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.409.67M
Float327.93M
Insiders14.83%
Institutions2.35%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap25.15M SEK
Enterprise Value13.80M SEK
Revenue (TTM)649.00K SEK
Gross Profit12.44M SEK
Net Income (TTM)-56.08M SEK
Revenue/Share0.0070 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price0.0637 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—